Vanguard Group
PROK icon

Vanguard Group’s ProKidney PROK Stock Holding History

Vanguard Group’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$3.69M Buy
1,648,229
+84,113
+5% +$221K ﹤0.01% 3365
2025
Q3 		$3.79M Sell
1,564,116
-3,752
-0.2% -$9.99K ﹤0.01% 3363
2025
Q2 		$928K Sell
1,567,868
-3,643,955
-70% -$2.84M ﹤0.01% 3763
2025
Q1 		$4.57M Sell
5,211,823
-63,882
-1% -$88.7K ﹤0.01% 3213
2024
Q4 		$8.92M Buy
5,275,705
+60,350
+1% +$109K ﹤0.01% 3014
2024
Q3 		$10M Buy
5,215,355
+1,240,071
+31% +$2.81M ﹤0.01% 2960
2024
Q2 		$9.78M Buy
3,975,284
+2,162,205
+119% +$5.8M ﹤0.01% 2942
2024
Q1 		$2.97M Sell
1,813,079
-1,085,965
-37% -$1.6M ﹤0.01% 3468
2023
Q4 		$5.16M Sell
2,899,044
-392,815
-12% -$842K ﹤0.01% 3274
2023
Q3 		$15.1M Buy
3,291,859
+229,078
+7% +$2.19M ﹤0.01% 2672
2023
Q2 		$34.3M Sell
3,062,781
-1,094,397
-26% -$11.6M ﹤0.01% 2358
2023
Q1 		$47.1M Buy
4,157,178
+3,974,528
+2,176% +$42.3M ﹤0.01% 2206
2022
Q4 		$1.25M Buy
182,650
+30,550
+20% +$292K ﹤0.01% 3833
2022
Q3 		$1.37M Buy
+152,100
New +$1.32M ﹤0.01% 3892

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $499M AUM 186.05% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BU
Brown University Providence, Rhode Island $102M AUM 26.79% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group's PROK Position: Q4 2025 in Review

Vanguard Group increased its ProKidney (PROK) stake by 5.4% in Q4 2025, buying an estimated $221K and bringing the position to 1,648,229 shares worth $3.69M. The position accounts for ﹤0.01% of the portfolio, ranked #3365.

Vanguard Group first reported a position in PROK in Q3 2022 and has held it in 14 quarters since. The position peaked at $47.1M in Q1 2023. 63 funds tracked by Wall St. Rank hold PROK as of Q4 2025.

  • Vanguard Group held 1,648,229 shares of ProKidney worth $3.69M as of Q4 2025.
  • Vanguard Group bought 84,113 ProKidney shares in Q4 2025, an estimated $221K.
  • ProKidney made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3365 holding.
  • Vanguard Group first reported a position in ProKidney in Q3 2022 and has held it in 14 quarters since.
  • Vanguard Group's ProKidney position peaked at $47.1M in Q1 2023.
  • 63 funds tracked by Wall St. Rank held ProKidney as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.